|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Total Cash and Cash Equivalents | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $591,291 and $632,258, respectively) | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $113,975 and $119,029, respectively) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $662,512 and $690,485, respectively) | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $99,157 and $104,371, respectively) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Nonmarketable equity securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Other borrowed funds | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| COMMITMENTS AND CONTINGENCIES | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, no par value: Authorized - $1,000,000 shares; None Issued and Outstanding | ||||||||||||||||||||
| Common stock, no par value: Authorized - $30,000,000 shares; Issued and Outstanding - $6,584,696 and $6,576,609 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity |
Loading...
